Myron Schwartz

Myron Schwartz

Icahn School of Medicine at Mount Sinai

H-index: 103

North America-United States

Contact Myron Schwartz

About Myron Schwartz

Myron Schwartz, With an exceptional h-index of 103 and a recent h-index of 57 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of hepatobiliary surgery, liver transplantation, liver cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Improved Outcomes of Liver Resection for Hepatitis C-related Hepatocellular Carcinoma After the Introduction of Direct-Acting Antiviral Therapy

48 Analyzing Changing Trends in Hepatocellular Carcinoma

Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis

Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

Immunotherapy and Transplantation for Hepatocellular Carcinoma

Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus–and Hepatitis C Virus–Related Hepatocellular Carcinoma

Myron Schwartz Information

University	Icahn School of Medicine at Mount Sinai
Position	Professor of Surgery
Citations(all)	58467
Citations(since 2020)	21078
Cited By	44064
hIndex(all)	103
hIndex(since 2020)	57
i10Index(all)	354
i10Index(since 2020)	191
Email	Access Email
University Profile Page	Icahn School of Medicine at Mount Sinai
Google Scholar	View Google Scholar Profile

Myron Schwartz Skills & Research Interests

hepatobiliary surgery

liver transplantation

liver cancer

Top articles of Myron Schwartz

Improved Outcomes of Liver Resection for Hepatitis C-related Hepatocellular Carcinoma After the Introduction of Direct-Acting Antiviral Therapy

HPB

2024/4/30

Myron Schwartz

H-Index: 53

48 Analyzing Changing Trends in Hepatocellular Carcinoma

Journal of Clinical and Translational Science

2024/4

Myron Schwartz

H-Index: 53

Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma

British Journal of Surgery

2024/3

Myron Schwartz

H-Index: 53

Wei Qiu

H-Index: 6

Zhong Chen

H-Index: 3

Jie Li

H-Index: 1

Hong Wang

H-Index: 8

Chao Li

H-Index: 8

Matteo Cescon

H-Index: 41

Feng Shen

H-Index: 6

Tian Yang

H-Index: 9

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

2024/2/29

Mark Yarchoan

H-Index: 27

Myron Schwartz

H-Index: 53

Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Analysis

Annals of Surgical Oncology

2024/2/9

Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

BJC Reports

2024/1/29

Sara Lewis

H-Index: 25

Myron Schwartz

H-Index: 53

Immunotherapy and Transplantation for Hepatocellular Carcinoma

2024/1/20

Myron Schwartz

H-Index: 53

Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus–and Hepatitis C Virus–Related Hepatocellular Carcinoma

Journal of Clinical Oncology

2024/1/4

Pei-Chien Tsai

H-Index: 23

Dae Won Jun

H-Index: 26

Yasuhito Tanaka

H-Index: 12

Hiroshi Abe

H-Index: 22

Takanori Suzuki

H-Index: 15

Myron Schwartz

H-Index: 53

Carlos Esquivel

H-Index: 2

Ming-Lung Yu

H-Index: 39

Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response

Alimentary Pharmacology & Therapeutics

2024/1/3

Jung Eun Park

H-Index: 11

Hiroshi Abe

H-Index: 22

Dae Won Jun

H-Index: 26

Qiang Xu

H-Index: 10

Scott Barnett

H-Index: 5

Yasuhito Tanaka

H-Index: 12

Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy

European Radiology

2024/1

Daniel Stocker

H-Index: 6

Myron Schwartz

H-Index: 53

Edward Kim

H-Index: 4

Novel Benchmark Values for Open Major Anatomic Liver Resection in Non-cirrhotic Patients

Annals of surgery

2023/11/1

Fabian Bartsch

H-Index: 5

Jeroen Hagendoorn

H-Index: 19

Tim Reese

H-Index: 2

Muhammad Haroon

H-Index: 1

Qian Lu

H-Index: 10

Myron Schwartz

H-Index: 53

Matteo Cescon

H-Index: 41

Takehiro Noji

H-Index: 15

William C Chapman

H-Index: 40

Tomoki Ebata

H-Index: 35

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification

Gut

2023/1/1

Huan Wang

H-Index: 4

Michael Donovan

H-Index: 0

Myron Schwartz

H-Index: 53

Augusto Villanueva

H-Index: 62

Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study

Gastroenterology

2023/10/1

Neehar Parikh

H-Index: 29

Myron Schwartz

H-Index: 53

Alex Befeler

H-Index: 16

Sudhir Srivastava

H-Index: 5

Semiautomated segmentation of hepatocellular carcinoma tumors with MRI using convolutional neural networks

European Radiology

2023/9

Guillermo Carbonell

H-Index: 3

Daniel Stocker

H-Index: 6

Myron Schwartz

H-Index: 53

Sara Lewis

H-Index: 25

Hayit Greenspan

H-Index: 39

Metabolomic liquid biopsy dynamics predict early onset of human hepatocarcinogenesis

Zeitschrift für Gastroenterologie

2023/8

Tim Daniel Rose

H-Index: 2

Tumor burden in patients with early and intermediate-stage hepatocellular carcinoma undergoing liver resection: a retrospective multicenter study on clinical and oncological …

HPB

2023/7/1

David Martin

H-Index: 7

Myron Schwartz

H-Index: 53

Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

Nature medicine

2023/6

Pauline Hamon

H-Index: 9

Nausicaa Malissen

H-Index: 9

Bruno Giotti

H-Index: 5

Zhen Zhao

H-Index: 7

Yi Wei

H-Index: 3

Wei Wang

H-Index: 14

Kunal Kundu

H-Index: 7

Nicolas Fernandez

H-Index: 8

Jiang He

H-Index: 10

Namita T Gupta

H-Index: 8

Myron Schwartz

H-Index: 53

Miriam Merad

H-Index: 86

816 RACIAL AND ETHNIC DISPARITIES IN DIRECT-ACTING ANTIVIRAL (DAA) TREATMENT AND SURVIVAL OUTCOMES FOR TREATED/SVR (SUSTAINED VIROLOGIC RESPONSE) AND UNTREATED/NON-SVR PATIENTS …

Gastroenterology

2023/5/1

Jung Eun Park

H-Index: 11

Pei-Chien Tsai

H-Index: 23

Hiroshi Abe

H-Index: 22

Dae Won Jun

H-Index: 26

Qiang Xu

H-Index: 10

Daniel Huang

H-Index: 6

Yasuhito Tanaka

H-Index: 12

Myron Schwartz

H-Index: 53

Ming-Lung Yu

H-Index: 39

Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis

Cancer Medicine

2023/5

Nicolas Goossens

H-Index: 24

Sara Lewis

H-Index: 25

Yujin Hoshida

H-Index: 57

Myron Schwartz

H-Index: 53

Circulating tumor DNA (ctDNA) correlates closely with tumor necrosis and relapse-free survival (RFS) in hepatocellular carcinoma (HCC) patients treated with perioperative …

Cancer Research

2023/4/4

Pauline Hamon

H-Index: 9

Edward Kim

H-Index: 4

Siyu Li

H-Index: 1

Elizabeth Miller

H-Index: 13

Miriam Merad

H-Index: 86

See List of Professors in Myron Schwartz University(Icahn School of Medicine at Mount Sinai)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine